Major Depressive Disorder (MDD) remains one of the most prevalent and disabling conditions worldwide. While antidepressant medications and psychotherapy are effective for many, a substantial number of patients experience incomplete or diminishing responses over time. For these individuals, Transcranial Magnetic Stimulation (TMS) offers a scientifically validated, non-invasive treatment that directly targets the neural circuits involved in mood regulation.
At Resiliency Mind Body Medicine, TMS is not simply a device-based intervention; it is part of a holistic, measurement-based model designed to restore harmony between mind and body. Each treatment plan is guided by a comprehensive evaluation, objective progress tracking, and a deep appreciation of each individual’s lived experience. By uniting neuroscience, advanced technology, and compassionate care, the team at Resiliency Mind Body Medicine defines a new era in personalized depression care, one that balances clinical precision with authentic human connection.
Understanding Depression and the Limits of Conventional Treatment
Depression is not merely a biochemical imbalance; it is a condition rooted in disrupted neural communication within the prefrontal-limbic network, which governs emotion, motivation, and cognitive flexibility. Traditional therapies such as selective serotonin reuptake inhibitors (SSRIs) aim to restore neurotransmitter balance but often fail to correct the underlying circuit dysfunction. Clinical data indicate that up to one-third of patients with MDD develop treatment-resistant depression (TRD), defined as the failure to achieve remission after at least two adequate antidepressant trials. For these individuals, continued reliance on medication adjustments may increase side effects without meaningful improvement. Recent updates from the American Psychiatric Association (APA) and the CANMAT 2023 guidelines emphasize early escalation to evidence-based interventional therapies like TMS once treatment resistance is established. This ensures timely intervention before chronic neural maladaptation occurs.How TMS Works: Targeting the Depressive Circuit
TMS works by delivering focused magnetic pulses to the dorsolateral prefrontal cortex (DLPFC), a region shown to exhibit reduced activity in depression. These pulses stimulate neuronal firing and enhance synaptic plasticity, effectively “retraining” the brain’s communication between the prefrontal cortex and deeper limbic structures such as the amygdala and hippocampus. Over repeated sessions, TMS helps normalize connectivity within these mood-regulating networks, improving emotional balance, cognitive clarity, and resilience. Importantly, this process occurs without systemic medication, sedation, or invasive procedures. At Resiliency Mind Body Medicine, the team uses BrainsWay Deep TMS™ technology, an advanced, FDA-cleared system that stimulates deeper and broader cortical regions than traditional TMS. This deep stimulation enhances effectiveness for patients with treatment-resistant or anxious depression. Treatment typically involves five sessions per week for six to eight weeks, with each session lasting about 20–30 minutes. Patients remain awake, experience minimal discomfort, and can immediately resume normal activities afterward. Side effects are generally mild, such as brief scalp sensitivity or headache, which resolve on their own.Evidence-Based Outcomes and Clinical Effectiveness
Strong scientific evidence supports TMS as a safe and effective treatment for major depressive disorder. The FDA first cleared TMS in 2008 based on trials showing significant improvements in response and remission rates compared to placebo treatments. Since then, multiple meta-analyses and real-world studies have validated these outcomes. A 2022 JAMA Psychiatry review reported that response rates to repetitive TMS (rTMS) in TRD populations reach 60–70%, with remission rates approaching 50% in certain protocols. BrainsWay Deep TMS™ systems have demonstrated even higher efficacy in patients with treatment-resistant depression and co-occurring anxiety symptoms. Beyond symptom relief, many patients report improved motivation, concentration, sleep quality, and engagement in therapy, making TMS a catalyst that enhances other treatment modalities.When to Consider TMS as the Next Step
Determining when to transition to TMS is crucial. Prolonged nonresponse to medication can reinforce maladaptive brain circuits and make recovery more difficult. TMS should be considered for patients who:- Have not achieved remission after at least two adequate antidepressant trials
- Cannot tolerate further medication due to side effects or medical conditions
- Prefer a non-drug, non-invasive treatment
- Continue to experience residual cognitive or emotional symptoms despite therapy
Integrating TMS into a Holistic Model of Care
At Resiliency Mind Body Medicine, TMS is integrated within a broader, whole-person care framework. Before starting therapy, each patient undergoes a comprehensive diagnostic evaluation, including assessment of depression severity, treatment history, and objective symptom tracking using validated tools like the PHQ-9 or HAM-D. The team follows a measurement-based approach, ensuring progress is tracked throughout treatment. This enables real-time adjustments, transparent communication, and alignment with payer authorization requirements when applicable. TMS is often paired with ongoing psychotherapy, lifestyle modifications, and somatic regulation techniques to support lasting recovery. This integrated model acknowledges that depression is both a brain and body disorder, requiring a multidimensional path to healing.What Patients Can Expect During TMS Treatment
Each TMS session is performed in-office by trained clinical staff. The BrainsWay coil is positioned precisely over the patient’s scalp to target the prefrontal cortex. Patients may feel a light tapping sensation as magnetic pulses are delivered. Most patients complete a standard six- to eight-week course, with gradual symptom improvement beginning around the third or fourth week. Because TMS has no cognitive side effects, patients can drive, work, or resume daily activities immediately after each session. The absence of systemic drug exposure makes TMS especially suitable for individuals who are medication-sensitive or prefer non-pharmacologic care.Ideal Candidates for TMS
Ideal candidates for TMS therapy include individuals who:- Have depression unresponsive to medications or therapy
- Experience intolerable side effects from antidepressants
- Prefer a medication-free treatment option
- Have stable medical and neurological health without contraindicated implants